Have a personal or library account? Click to login
Structure-Activity Approach in the Reactivation of Tabun-Phosphorylated Human Acetylcholinesterase with Bispyridinium para-Aldoximes Cover

Structure-Activity Approach in the Reactivation of Tabun-Phosphorylated Human Acetylcholinesterase with Bispyridinium para-Aldoximes

Open Access
|Jun 2007

References

  1. Gray AP. Design and structure-activity relationships of antidotes to organophosphorus anticholinesterase agents. Drug Metab Rev 1984;15, 557-89.10.3109/03602538409029973
  2. Stojiljković MP, Jokanović M. Pyridinium oximes: rationale for their selection as causal antidotes against organophosphate poisonings and current solutions for auto-injectors. Arh Hig Rada Toksikol 2006;57:435-43.
  3. Čalić M, Lucić Vrdoljak A, Radić B, Jelić D, Jun D, Kuča K, Kovarik Z. In vitro and in vivo evaluation of pyridinium aldoximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity. Toxicology 2006;219:85-96.10.1016/j.tox.2005.11.003
  4. Lucić Vrdoljak A, Čalić M, Radić B, Berend S, Jun D, Kuča K, Kovarik Z. Pretreatment with pyridinium aldoximes improves antidotal therapy against tabun poisoning. Toxicology 2006;228:41-50.10.1016/j.tox.2006.08.012
  5. Simeon-Rudolf V, Reiner E, Škrinjarić-Špoljar M, Radić B, Lucić A, Primožić I, Tomić S. Quinuclidinium-imidazolium compounds: synthesis, mode of interaction with acetylcholinesterase and effect upon soman intoxicated mice. Arch Toxicol 1998;72:289-95.10.1007/s002040050504
  6. Škrinjarić-Špoljar M, Burger N, Lovrić J. Inhibition of acetylcholinesterase by three new pyridinium compounds and their effect on phosphonylation of the enzyme. J Enzym Inhib 1999;14:331-41.10.3109/14756369909030327
  7. Kovarik Z, Bosak A, Šinko G, Latas T. Exploring active sites of cholinesterases by inhibition with bambuterol and haloxon. Croat Chem Acta 2003;76:63-7.
  8. Šinko G, Bosak A, Kovarik Z, Simeon-Rudolf V. Structure-inhibition relationships in the interaction of butyrylcholinesterase with bambuterol, haloxon and their leaving groups. Chem-Biol Interact 2005;157-158:421-3.10.1016/j.cbi.2005.10.087
  9. Ellman GL, Courtney KD, Andres VJr, Featherstone RM. New and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-95.10.1016/0006-2952(61)90145-9
  10. Eyer P, Worek F, Kiderlen D, Šinko G, Štuglin A, Simeon-Rudolf V, Reiner E. Molar absorption coefficients for the reduced Ellman reagent: reassessment. Anal Biochem 2003;312:224-7.10.1016/S0003-2697(02)00506-7
  11. Šinko G, Čalić M, Kovarik Z. para- and ortho-Pyridinium aldoximes in reaction with acetylthiocholine. FEBS Lett 2006;580:3167-72.10.1016/j.febslet.2006.04.07016684539
  12. Odžak R, Čalić M, Hrenar T, Primožić I, Kovarik Z. Evaluation of monoquaternary pyridinium aldoximes potency to reactivate tabun-inhibited human acetylcholinesterase. Toxicology 2006;233:85-96.10.1016/j.tox.2006.08.00316962227
  13. Kovarik Z, Radić Z, Berman HA, Simeon-Rudolf V, Reiner E, Taylor P. Mutant cholinesterases possessing enhanced capacity for reactivation of their phosphonylated conjugates. Biochemistry 2004;43:3222-9.10.1021/bi036191a
  14. Heilbronn E. In vitro reactivation and "aging" of tabun-inhibited blood cholinesterases studied with N-methyl-pyridinium-2-aldoxime methane sulphonate and N,N'-trimethylene bis (pyridinium-4-aldoxime) dibromide. Biochem Pharmacol 1963;12:25-36.10.1016/0006-2952(63)90006-6
  15. Ashani Y, Bhattacharjee AK, Leader H, Saxena A, Doctor BP. Inhibition of cholinesterase with cationic phosphonyl oximes highlights distinctive properties of the charged pyridine groups of quaternary oxime reactivators. Biochem Pharmacol 2003;33:191-202.10.1016/S0006-2952(03)00204-1
  16. Francisković L, Škrinjarić-Špoljar M, Reiner E. Interaction of imidazolium and pyridinium dioximes with human erythrocyte acetylcholinesterase. Chem-Biol Interact 1993;87:323-8.10.1016/0009-2797(93)90060-C
  17. Kuča K, Patočka J, Cabal J. Reactivation of organophosphate inhibited acetylcholinesterase activity by α, ω-bis-(hydroxyiminomethylpyridinium)alkanes in vitro.J Appl Biomed 2003;1:207-11.10.32725/jab.2003.037
  18. Worek F, Thiermann H, Szinicz L, Eyer P. Kinetic analysis of interactions between human acetylcholineserase, structurally different organophosphorus compounds and aldoximes. Biochem Pharmacol 2004;68:2237-48.10.1016/j.bcp.2004.07.038
  19. Pang Y-P, Kollmeyer TM, Hong F, Lee J, Hammond PI, Haugabouk SP, Brimijoin S. Rational design of alkylene-linked bis-pyridiniumaldoximes as improved acetylcholinesterase reactivators. Chem Biol 2003;10:491-502.10.1016/S1074-5521(03)00126-1
  20. Ekström F, Pang Y-P, Boman M, Artursson E, Akfur C, Börjegren S. Crystal structures of acetylcholinesterase in complex with HI-6, Ortho-7 and obidoxime: Structural basis for differences in the ability to reactivate tabun conjugates. Biochem Pharmacol 2006;72:597-607.10.1016/j.bcp.2006.05.02716876764
  21. Bosak A, Primožić I, Oršulić M, Tomić S, Simeon-Rudolf V. Enantiomers of quinuclidin-3-ol derivates: resolution and interactions with human cholinesterases. Croat Chem Acta 2005;78:121-8.
  22. Simeon V, Radić Z, Reiner E. Inhibition of cholinesterase by the aldoximes P2AM and toxogonin. Croat Chem Acta 1981;54:473-80.
  23. Škrinjarić-Špoljar M, Simeon V, Reiner E, Krauthacker B. Bispyridinium compounds: inhibition of human erythrocyte acetylcholinesterase and protection of the enzyme against phosphylation. Acta Pharm Jugosl 1988;38:101-9.
  24. Kovarik Z, Ciban N, Radić Z, Simeon-Rudolf V, Taylor P. Active site mutant acetylcholinesterase interactions with 2-PAM, HI-6, and DDVP. Biochem Biophys Res Commun 2006;342:973-8.10.1016/j.bbrc.2006.02.05616598855
  25. Reiner E. Inhibition of acetylcholinesterase by 4,4'-bipyridine and its effect upon phosphylation of the enzyme. Croat Chem Acta 1986;59:925-31.
DOI: https://doi.org/10.2478/v10004-007-0013-7 | Journal eISSN: 1848-6312 | Journal ISSN: 0004-1254
Language: English, Slovenian
Page range: 201 - 209
Published on: Jun 11, 2007
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2007 Zrinka Kovarik, Maja Čalić, Goran Šinko, Anita Bosak, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons License.

Volume 58 (2007): Issue 2 (June 2007)